Randomized trials and quality assurance in gastric cancer surgery

被引：8

作者：

Dikken, Johan L. ^{[1
,2
]}

Cats, Annemieke ^{[3
]}

Verheij, Marcel ^{[2
]}

van de Velde, Cornelis J. H. ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Surg, NL-2300 RC Leiden, Netherlands

[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands

[3] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Gastroenterol, Amsterdam, Netherlands

来源：

JOURNAL OF SURGICAL ONCOLOGY | 2013年 / 107卷 / 03期

关键词：

stomach neoplasms; surgical procedures; operative; gastrectomy; randomized controlled trial; quality assurance; health care; ASSISTED DISTAL GASTRECTOMY; LYMPH-NODE DISSECTION; PHASE-III TRIAL; CLINICAL-PRACTICE GUIDELINES; IN-HOSPITAL MORTALITY; LONG-TERM SURVIVAL; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; NEOADJUVANT CHEMOTHERAPY; SURGICAL QUALITY;

D O I：

10.1002/jso.23080

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A D2 lymphadenectomy can be considered standard of surgical care for advanced resectable gastric cancer. Currently, several multimodality strategies are used, including postoperative monochemotherapy in Asia, postoperative chemoradiotherapy in the United States, and perioperative chemotherapy in Europe. As the majority of gastric cancer patients are treated outside the framework of clinical trials, quality assurance programs, including referral to high-volume centers and clinical auditing are needed to improve gastric cancer care on a nationwide level. J. Surg. Oncol. 2013;107:298305. (c) 2012 Wiley Periodicals, Inc.

引用

页码：298 / 305

页数：8

共 102 条

[1] Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma [J].

Ajani, JA ;

Faust, J ;

Ikeda, K ;

Yao, JC ;

Anbe, H ;

Carr, KL ;

Houghton, M ;

Urrea, P .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) :6957-6965

[2] Gastric Cancer Clinical Practice Guidelines in Oncology™ [J].

Ajani, Jaffer A. ;

Barthel, James S. ;

Bekaii-Saab, Tanios ;

Bentrem, David J. ;

D'Amico, Thomas A. ;

Das, Prajnan ;

Denlinger, Crystal ;

Fuchs, Charles S. ;

Gerdes, Hans ;

Hayman, James A. ;

Hazard, Lisa ;

Hofstetter, Wayne L. ;

Ilson, David H. ;

Keswani, Rajesh N. ;

Kleinberg, Lawrence R. ;

Korn, Michael ;

Meredith, Kenneth ;

Mulcahy, Mary F. ;

Orringer, Mark B. ;

Osarogiagbon, Raymond U. ;

Posey, James A. ;

Sasson, Aaron R. ;

Scott, Walter J. ;

Shibata, Stephen ;

Strong, Vivian E. M. ;

Washington, Mary Kay ;

Willett, Christopher ;

Wood, Douglas E. ;

Wright, Cameron D. ;

Yang, Gary .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (04) :378-409

[3] Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial [J].

Ajani, Jaffer A. ;

Rodriguez, Wuilbert ;

Bodoky, Gyorgy ;

Moiseyenko, Vladimir ;

Lichinitser, Mikhail ;

Gorbunova, Vera ;

Vynnychenko, Ihor ;

Garin, August ;

Lang, Istvan ;

Falcon, Silvia .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) :1547-1553

[4]

[Anonymous], 1990, Cancer, V66, P2324

[5]

[Anonymous], J CLIN ONCOL S

[6]

[Anonymous], 2009, SEER CANC STAT REV 1

[7]

[Anonymous], 1998, GASTRIC CANCER, V1, P10

[8]

[Anonymous], ANN SURG

[9]

[Anonymous], 2003, COCHRANE DB SYST REV

[10] Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers [J].

Bachmann, MO ;

Alderson, D ;

Edwards, D ;

Wotton, S ;

Bedford, C ;

Peters, TJ ;

Harvey, IM .

BRITISH JOURNAL OF SURGERY, 2002, 89 (07) :914-922

← 1 2 3 4 5 6 7 8 9 10 →